8/103 sources · 3 publishersUpdated Oct 30, 13:42 UTC
AstraZeneca posts strong Q3 results and announces $1.5 bn restructuring plan
AstraZeneca reported a 23% jump in third‑quarter profit to $3.12 billion and a 7% rise in revenue, while unveiling a restructuring programme expected to save $1.5 billion. The results lifted the share price sharply on the FTSE 100, offsetting a steep fall in NatWest and modest gains in BP. Analysts highlighted the drug maker’s diversified pipeline as a key growth driver.
Why it matters
The company expects the cost‑saving plan to improve margins and fund future pipeline investments, which could boost cash flow for shareholders. NatWest’s 7.9% drop reflects weaker banking earnings, pressuring the FTSE 100’s financial sector.
Key facts
- 1AstraZeneca announced a restructuring drive that will likely save $1.5 billion. globalbankingandfinance.com
- 2Third‑quarter profit rose 23% to $3.12 billion. rttnews.com
- 3Earnings per share increased from $1.62 to $2.00. rttnews.com
- 4Total revenue grew 7% at constant exchange rates. ukinvestormagazine.co.uk
- 5NatWest shares fell 7.9% after disappointing earnings. globalbankingandfinance.com
- 6BP posted a record quarterly net profit, lifting its share price modestly. globalbankingandfinance.com
Summary written by AlphAI AI Desk from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.